Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124804093 | 12480409 | 3 | F | 20160721 | 20160620 | 20160804 | EXP | US-ACORDA-ACO_124975_2016 | ACORDA | 0.00 | Y | 0.00000 | 20160804 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124804093 | 12480409 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Unknown | UNK | U | U | 22250 | TABLET | |||||||
| 124804093 | 12480409 | 2 | C | TYSABRI | NATALIZUMAB | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124804093 | 12480409 | 1 | Product used for unknown indication |
| 124804093 | 12480409 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124804093 | 12480409 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124804093 | 12480409 | Abasia | |
| 124804093 | 12480409 | Fatigue | |
| 124804093 | 12480409 | Gait disturbance | |
| 124804093 | 12480409 | Limb discomfort | |
| 124804093 | 12480409 | Multiple sclerosis relapse | |
| 124804093 | 12480409 | Muscle spasms | |
| 124804093 | 12480409 | Walking aid user |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |